Quantification of biotherapeutic targets: new opportunities with immunoaffinity LC-MS/MS
Hendrik Neubert1, Joe Palandra, Mireia Fernández Ocaña
1Pfizer Inc., Pfizer Worldwide Research & Development, Pharmacokinetics Dynamics & Metabolism, 1 Burtt Road, Andover, MA 01810, USA.
Bioanalysis
|August 27, 2014
Abstract
No abstract available in PubMed .


